Blow to Funds and Morale | GenomeWeb

If the sequestration cuts go into effect at the beginning of March, it will be a "profound and devastating blow" to biomedical research in the US, National Institutes of Health Director Francis Collins tells Politico. The original deadline to avoid those cuts was at the beginning of January, but lawmakers were able to come to an agreement to delay their enactment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.